Novel subcutaneous (hypodermoclysis) infusion delivery system based on osmotic pump


#IVTEAM #Intravenous literature: Gong, W., Ma, R., Mei, D., Jing, P., Dong, X., Li, B., Yang, Y., Du, L., Mei, X.G. and Hu, F.Q. (2013) A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation. Drug Delivery. October 9th. .


An economical, convenient portable drug delivery system combining osmotic pump with subcutaneous infusion was developed, which was composed of three primary components: water chamber, osmotic pump chamber and support base. Ceftriaxone sodium (CRO) was selected as the model drug and osmotic pump tablets were prepared. The influence of osmotic agents on drug release profiles was evaluated. As the adjustment made by the osmotic agents was limited, the compositions of semipermeable membrane were investigated to determine significant associations of factors based on orthogonal design. The in vitro release profiles of the optimum formulation achieved to the predetermined value (15 ± 3 min for the initial release time Ti and 5.75 ± 0.25 h for the extent release time Te). The pharmacokinetic profiles of this drug delivery system were evaluated in Beagle dogs. In vivo results demonstrated that the osmotic pump subcutaneous infusion administration was equivalent to intravenous injection administration in terms of bioavailability. Moreover, constant drug plasma levels with minimized fluctuations could be achieved with this osmotic pump subcutaneous infusion system, compared with intravenous injection.

Main page


Comments are closed.